312 related articles for article (PubMed ID: 29772460)
1. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
Kunc M; Biernat W; Senkus-Konefka E
Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
[TBL] [Abstract][Full Text] [Related]
6. Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay.
Gritzapis AD; Baxevanis CN; Missitzis I; Katsanou ES; Alexis MN; Yotis J; Papamichail M
Breast Cancer Res Treat; 2003 Jul; 80(1):1-13. PubMed ID: 12889594
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
[TBL] [Abstract][Full Text] [Related]
8. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.
Elledge RM; Ciocca DR; Langone G; McGuire WL
Cancer; 1993 Apr; 71(8):2499-506. PubMed ID: 8095853
[TBL] [Abstract][Full Text] [Related]
11. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
12. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
Redkar AA; Kabre SS; Mittra I
Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
[TBL] [Abstract][Full Text] [Related]
13. Receptor levels in breast cancer.
Nardelli GB; Lamaina V; Marson S; Miola G
Eur J Gynaecol Oncol; 1988; 9(1):54-8. PubMed ID: 3345786
[TBL] [Abstract][Full Text] [Related]
14. Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer.
Nikolic-Vukosavljevic D; Kanjer K; Neskovic-Konstantinovic Z; Vukotic D
Int J Biol Markers; 2002; 17(3):196-200. PubMed ID: 12408471
[TBL] [Abstract][Full Text] [Related]
15. [Hormone receptors (ER, PgR) as a prognostic factor in breast cancer].
Kimura M; Koida T; Shimizu Y; Fukuda T; Sakaue S; Nakamura S
Gan No Rinsho; 1988 Aug; 34(9):1083-8. PubMed ID: 3172513
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
Arpino G; Weiss HL; Clark GM; Hilsenbeck SG; Osborne CK
J Clin Oncol; 2005 Jul; 23(21):4687-94. PubMed ID: 15837971
[TBL] [Abstract][Full Text] [Related]
19. Hormone receptors and Japanese breast cancer.
Matsumoto K; Kitamura Y; Sugano H
Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
[TBL] [Abstract][Full Text] [Related]
20. [A study on the relationship among estrogen receptor, progesterone receptor and glucose-6-phosphate dehydrogenase activity in primary breast cancer].
Zeng QF; Xu JH
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):107-9. PubMed ID: 1914015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
